Cargando…
The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer’s disease: results from a randomized controlled trial
BACKGROUND: Synaptic dysfunction contributes to cognitive impairment in Alzheimer’s disease and may be countered by increased intake of nutrients that target brain phospholipid metabolism. In this study, we explored whether the medical food Souvenaid affects brain phospholipid metabolism in patients...
Autores principales: | Rijpma, Anne, van der Graaf, Marinette, Lansbergen, Marieke M., Meulenbroek, Olga, Cetinyurek-Yavuz, Aysun, Sijben, John W., Heerschap, Arend, Olde Rikkert, Marcel G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530581/ https://www.ncbi.nlm.nih.gov/pubmed/28747210 http://dx.doi.org/10.1186/s13195-017-0286-2 |
Ejemplares similares
-
Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional (31)P MR spectroscopic imaging study
por: Rijpma, Anne, et al.
Publicado: (2018) -
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015) -
The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study
por: de Waal, Hanneke, et al.
Publicado: (2014) -
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
por: de Wilde, Martijn C., et al.
Publicado: (2017) -
Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)